Neuroprotective effects of phytocannabinoid-based medicines in experimental models of Huntington’s disease (PubMed)
Cannabinoids: Novel medicines for the treatment of Huntington’s disease (PubMed)
Sativex-like combination of phytocannabinoids is neuroprotective in malonate-lesioned rats, an inflammatory model of Huntington’s disease: role of CB(1) and CB(2) receptors (PubMed)
Controlled clinical trial of cannabidiol in Huntington’s disease (PubMed)
Prospects for cannabinoid therapies in basal ganglia disorders (PubMed)
Neuroprotective Properties of Cannabigerol in Huntington’s Disease: Studies in R6/2 Mice and 3-Nitropropionate-lesioned Mice (PubMed)
© 2020 Sciva Corporation s.r.o. All Rights Reserved.